← Back to Clinical Trials
Recruiting NCT04623424
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
Trial Parameters
Condition Stem Cell Transplant Complications
Sponsor Henry Ford Health System
Study Type OBSERVATIONAL
Phase N/A
Enrollment 255
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2020-11-03
Completion 2028-11-03
Interventions
intestinal microbiota
Brief Summary
In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18-80 years * patients undergoing allogenic or autologous SCT for malignant hematological conditions or bone marrow failure